GeneDx Holdings Corp. (WGS) EBIT

Annual EBIT:

-$23.21M+$146.98M(+86.36%)
December 31, 2024

Summary

  • As of today, WGS annual earnings before interest & taxes is -$23.21 million, with the most recent change of +$146.98 million (+86.36%) on December 31, 2024.
  • During the last 3 years, WGS annual EBIT has risen by +$219.34 million (+90.43%).
  • WGS annual EBIT is now at all-time high.

Performance

WGS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGSincome statement metrics

Quarterly EBIT:

-$3.12M-$12.16M(-134.57%)
September 30, 2025

Summary

  • As of today, WGS quarterly earnings before interest & taxes is -$3.12 million, with the most recent change of -$12.16 million (-134.57%) on September 30, 2025.
  • Over the past year, WGS quarterly EBIT has increased by +$4.29 million (+57.86%).
  • WGS quarterly EBIT is now -134.33% below its all-time high of $9.10 million, reached on December 31, 2024.

Performance

WGS Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGSincome statement metrics

TTM EBIT:

$11.02M+$4.29M(+63.74%)
September 30, 2025

Summary

  • As of today, WGS TTM earnings before interest & taxes is $11.02 million, with the most recent change of +$4.29 million (+63.74%) on September 30, 2025.
  • Over the past year, WGS TTM EBIT has increased by +$65.23 million (+120.32%).
  • WGS TTM EBIT is now at all-time high.

Performance

WGS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGSincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

WGS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+86.4%+57.9%+120.3%
3Y3 Years+90.4%+96.6%+102.5%
5Y5 Years+19.7%+94.4%+119.7%

WGS EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+94.9%-134.3%+97.1%at high+102.5%
5Y5-Yearat high+94.9%-134.3%+98.4%at high+102.5%
All-TimeAll-Timeat high+94.9%-134.3%+98.4%at high+102.5%

WGS EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$3.12M(-134.6%)
$11.02M(+63.7%)
Jun 2025
-
$9.03M(+326.2%)
$6.73M(+153.2%)
Mar 2025
-
-$3.99M(-143.9%)
-$12.64M(+41.1%)
Dec 2024
-$23.21M(+86.4%)
$9.10M(+222.8%)
-$21.46M(+60.4%)
Sep 2024
-
-$7.41M(+28.3%)
-$54.22M(+31.6%)
Jun 2024
-
-$10.33M(+19.4%)
-$79.30M(+33.3%)
Mar 2024
-
-$12.82M(+45.8%)
-$118.95M(+27.3%)
Dec 2023
-$170.19M(+62.8%)
-$23.66M(+27.2%)
-$163.68M(+33.9%)
Sep 2023
-
-$32.49M(+35.0%)
-$247.50M(+19.1%)
Jun 2023
-
-$49.98M(+13.1%)
-$305.82M(+25.3%)
Mar 2023
-
-$57.54M(+46.5%)
-$409.39M(+6.3%)
DateAnnualQuarterlyTTM
Dec 2022
-$457.51M(-88.6%)
-$107.48M(-18.4%)
-$436.81M(+1.9%)
Sep 2022
-
-$90.82M(+40.9%)
-$445.11M(-0.7%)
Jun 2022
-
-$153.55M(-80.7%)
-$442.17M(-33.6%)
Mar 2022
-
-$84.97M(+26.6%)
-$330.92M(+24.9%)
Dec 2021
-$242.56M(-1.5%)
-
-
Dec 2021
-
-$115.78M(-31.8%)
-$440.65M(+2.1%)
Sep 2021
-
-$87.87M(-107.8%)
-$449.92M(-7.6%)
Jun 2021
-
-$42.30M(+78.3%)
-$418.06M(-11.3%)
Mar 2021
-
-$194.70M(-55.7%)
-$375.76M(-107.5%)
Dec 2020
-$238.87M(-725.9%)
-$125.05M(-123.2%)
-$181.06M(-223.2%)
Sep 2020
-
-$56.02M
-$56.02M
Dec 2019
-$28.92M
-
-

FAQ

  • What is GeneDx Holdings Corp. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. annual EBIT year-on-year change?
  • What is GeneDx Holdings Corp. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. quarterly EBIT year-on-year change?
  • What is GeneDx Holdings Corp. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. TTM EBIT year-on-year change?

What is GeneDx Holdings Corp. annual earnings before interest & taxes?

The current annual EBIT of WGS is -$23.21M

What is the all-time high annual EBIT for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high annual earnings before interest & taxes is -$23.21M

What is GeneDx Holdings Corp. annual EBIT year-on-year change?

Over the past year, WGS annual earnings before interest & taxes has changed by +$146.98M (+86.36%)

What is GeneDx Holdings Corp. quarterly earnings before interest & taxes?

The current quarterly EBIT of WGS is -$3.12M

What is the all-time high quarterly EBIT for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high quarterly earnings before interest & taxes is $9.10M

What is GeneDx Holdings Corp. quarterly EBIT year-on-year change?

Over the past year, WGS quarterly earnings before interest & taxes has changed by +$4.29M (+57.86%)

What is GeneDx Holdings Corp. TTM earnings before interest & taxes?

The current TTM EBIT of WGS is $11.02M

What is the all-time high TTM EBIT for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high TTM earnings before interest & taxes is $11.02M

What is GeneDx Holdings Corp. TTM EBIT year-on-year change?

Over the past year, WGS TTM earnings before interest & taxes has changed by +$65.23M (+120.32%)
On this page